Paul R. Kirchgraber, CEO of Labcorp Holdings LH, has filed 0 purchases and 2 sales on the open market. The latest trade was on 23/05/19.

PK

PK

Paul R. Kirchgraber

CEO, Covance Drug Development

Company

Labcorp Holdings LH

First filing

23/02/07

Trades

19 trades

Buys / sales

0 / 2

12-month net buying

No record

Last trade

23/05/19

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Labcorp HoldingsLH	Open-market sale	23/05/19	23/05/23	4,300 sh	$216.91	$932,713	−24.9%
Labcorp HoldingsLH	Open-market sale	23/02/21	23/02/23	8,000 sh	$250.58	$2,004,640	−46.9%